Site icon LAGEPP

New collaboration between Skyepharma and LAGEPP Laboratory of Université Claude Bernard Lyon 1 and CNRS

The NanoMicS project will focus on lipidic nanoparticles, produced with the Microfluidizer® Technology. They allowing an efficient #encapsulation of low soluble APIs in digestive fluids and a significant improvement of their passage into the blood, thanks to their surface properties.

All informations on

Exit mobile version
Skip to toolbar